Project
SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Navigation
Downloads
Results for MYF6
Z-value: 2.91
Motif logo
Transcription factors associated with MYF6
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
MYF6
|
ENSG00000111046.3 | myogenic factor 6 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| MYF6 | hg19_v2_chr12_+_81101277_81101321 | -0.34 | 1.4e-01 | Click! |
Activity profile of MYF6 motif
Sorted Z-values of MYF6 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr19_-_18391708 | 16.76 |
ENST00000600972.1
|
JUND
|
jun D proto-oncogene |
| chr11_-_117747327 | 16.56 |
ENST00000584230.1
ENST00000527429.1 ENST00000584394.1 ENST00000532984.1 |
FXYD6
FXYD6-FXYD2
|
FXYD domain containing ion transport regulator 6 FXYD6-FXYD2 readthrough |
| chr5_-_139422654 | 16.42 |
ENST00000289409.4
ENST00000358522.3 ENST00000378238.4 ENST00000289422.7 ENST00000361474.1 ENST00000545385.1 ENST00000394770.1 ENST00000541337.1 |
NRG2
|
neuregulin 2 |
| chr9_-_131940526 | 13.61 |
ENST00000372491.2
|
IER5L
|
immediate early response 5-like |
| chr20_+_2673383 | 13.21 |
ENST00000380648.4
ENST00000342725.5 |
EBF4
|
early B-cell factor 4 |
| chr19_-_47734448 | 11.91 |
ENST00000439096.2
|
BBC3
|
BCL2 binding component 3 |
| chr7_-_11871815 | 10.22 |
ENST00000423059.4
|
THSD7A
|
thrombospondin, type I, domain containing 7A |
| chr8_+_31497271 | 9.27 |
ENST00000520407.1
|
NRG1
|
neuregulin 1 |
| chr7_-_99869799 | 9.24 |
ENST00000436886.2
|
GATS
|
GATS, stromal antigen 3 opposite strand |
| chr11_+_114168773 | 9.20 |
ENST00000542647.1
ENST00000545255.1 |
NNMT
|
nicotinamide N-methyltransferase |
| chr20_-_52790055 | 8.99 |
ENST00000395955.3
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1 |
| chr8_+_40010989 | 8.90 |
ENST00000315792.3
|
C8orf4
|
chromosome 8 open reading frame 4 |
| chr20_-_52790512 | 8.55 |
ENST00000216862.3
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1 |
| chr12_+_52445191 | 8.32 |
ENST00000243050.1
ENST00000394825.1 ENST00000550763.1 ENST00000394824.2 ENST00000548232.1 ENST00000562373.1 |
NR4A1
|
nuclear receptor subfamily 4, group A, member 1 |
| chr15_-_88799384 | 8.25 |
ENST00000540489.2
ENST00000557856.1 ENST00000558676.1 |
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3 |
| chr11_-_117698787 | 7.93 |
ENST00000260287.2
|
FXYD2
|
FXYD domain containing ion transport regulator 2 |
| chr6_+_7727030 | 7.87 |
ENST00000283147.6
|
BMP6
|
bone morphogenetic protein 6 |
| chr17_-_19648683 | 7.57 |
ENST00000573368.1
ENST00000457500.2 |
ALDH3A1
|
aldehyde dehydrogenase 3 family, member A1 |
| chr22_-_21905120 | 7.47 |
ENST00000331505.5
|
RIMBP3C
|
RIMS binding protein 3C |
| chr12_+_86268065 | 7.39 |
ENST00000551529.1
ENST00000256010.6 |
NTS
|
neurotensin |
| chr1_-_57045228 | 7.30 |
ENST00000371250.3
|
PPAP2B
|
phosphatidic acid phosphatase type 2B |
| chr3_-_129325660 | 7.21 |
ENST00000324093.4
ENST00000393239.1 |
PLXND1
|
plexin D1 |
| chr2_+_37571717 | 7.11 |
ENST00000338415.3
ENST00000404976.1 |
QPCT
|
glutaminyl-peptide cyclotransferase |
| chr2_+_37571845 | 7.08 |
ENST00000537448.1
|
QPCT
|
glutaminyl-peptide cyclotransferase |
| chr14_-_23288930 | 7.01 |
ENST00000554517.1
ENST00000285850.7 ENST00000397529.2 ENST00000555702.1 |
SLC7A7
|
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
| chr17_+_42634844 | 6.74 |
ENST00000315323.3
|
FZD2
|
frizzled family receptor 2 |
| chr6_-_127780510 | 6.72 |
ENST00000487331.2
ENST00000483725.3 |
KIAA0408
|
KIAA0408 |
| chr12_+_56075330 | 6.54 |
ENST00000394252.3
|
METTL7B
|
methyltransferase like 7B |
| chr15_-_27018175 | 6.53 |
ENST00000311550.5
|
GABRB3
|
gamma-aminobutyric acid (GABA) A receptor, beta 3 |
| chr4_+_2043689 | 6.48 |
ENST00000382878.3
ENST00000409248.4 |
C4orf48
|
chromosome 4 open reading frame 48 |
| chr17_-_47045949 | 6.36 |
ENST00000357424.2
|
GIP
|
gastric inhibitory polypeptide |
| chr14_+_31343951 | 6.05 |
ENST00000556908.1
ENST00000555881.1 ENST00000460581.2 |
COCH
|
cochlin |
| chr11_-_117698765 | 6.04 |
ENST00000532119.1
|
FXYD2
|
FXYD domain containing ion transport regulator 2 |
| chrX_-_30326445 | 5.91 |
ENST00000378963.1
|
NR0B1
|
nuclear receptor subfamily 0, group B, member 1 |
| chr19_+_35521572 | 5.91 |
ENST00000262631.5
|
SCN1B
|
sodium channel, voltage-gated, type I, beta subunit |
| chr3_+_32280159 | 5.89 |
ENST00000458535.2
ENST00000307526.3 |
CMTM8
|
CKLF-like MARVEL transmembrane domain containing 8 |
| chr11_-_46142948 | 5.88 |
ENST00000257821.4
|
PHF21A
|
PHD finger protein 21A |
| chr2_+_26915584 | 5.65 |
ENST00000302909.3
|
KCNK3
|
potassium channel, subfamily K, member 3 |
| chr19_+_35521616 | 5.59 |
ENST00000595652.1
|
SCN1B
|
sodium channel, voltage-gated, type I, beta subunit |
| chr6_+_136172820 | 5.55 |
ENST00000308191.6
|
PDE7B
|
phosphodiesterase 7B |
| chr2_-_220435963 | 5.49 |
ENST00000373876.1
ENST00000404537.1 ENST00000603926.1 ENST00000373873.4 ENST00000289656.3 |
OBSL1
|
obscurin-like 1 |
| chr3_-_129279894 | 5.48 |
ENST00000506979.1
|
PLXND1
|
plexin D1 |
| chr6_-_127837739 | 5.37 |
ENST00000368268.2
|
SOGA3
|
SOGA family member 3 |
| chr11_-_414948 | 5.29 |
ENST00000530494.1
ENST00000528209.1 ENST00000431843.2 ENST00000528058.1 |
SIGIRR
|
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain |
| chr22_+_18893736 | 5.26 |
ENST00000331444.6
|
DGCR6
|
DiGeorge syndrome critical region gene 6 |
| chr19_-_38747172 | 5.26 |
ENST00000347262.4
ENST00000591585.1 ENST00000301242.4 |
PPP1R14A
|
protein phosphatase 1, regulatory (inhibitor) subunit 14A |
| chr2_+_105471969 | 5.06 |
ENST00000361360.2
|
POU3F3
|
POU class 3 homeobox 3 |
| chr4_+_2043777 | 5.06 |
ENST00000409860.1
|
C4orf48
|
chromosome 4 open reading frame 48 |
| chr20_-_31071309 | 5.00 |
ENST00000326071.4
|
C20orf112
|
chromosome 20 open reading frame 112 |
| chr20_-_23731569 | 4.90 |
ENST00000304749.2
|
CST1
|
cystatin SN |
| chr7_-_74867509 | 4.90 |
ENST00000426327.3
|
GATSL2
|
GATS protein-like 2 |
| chr5_-_59189545 | 4.86 |
ENST00000340635.6
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific |
| chr14_-_54423529 | 4.83 |
ENST00000245451.4
ENST00000559087.1 |
BMP4
|
bone morphogenetic protein 4 |
| chr16_-_74808710 | 4.82 |
ENST00000219368.3
ENST00000544337.1 |
FA2H
|
fatty acid 2-hydroxylase |
| chr15_-_27184664 | 4.80 |
ENST00000541819.2
|
GABRB3
|
gamma-aminobutyric acid (GABA) A receptor, beta 3 |
| chr20_+_4129426 | 4.72 |
ENST00000339123.6
ENST00000305958.4 ENST00000278795.3 |
SMOX
|
spermine oxidase |
| chr4_-_139163491 | 4.71 |
ENST00000280612.5
|
SLC7A11
|
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 |
| chr11_-_66336060 | 4.60 |
ENST00000310325.5
|
CTSF
|
cathepsin F |
| chr21_+_37507210 | 4.60 |
ENST00000290354.5
|
CBR3
|
carbonyl reductase 3 |
| chr21_+_46875424 | 4.53 |
ENST00000359759.4
|
COL18A1
|
collagen, type XVIII, alpha 1 |
| chr21_+_46875395 | 4.50 |
ENST00000355480.5
|
COL18A1
|
collagen, type XVIII, alpha 1 |
| chr22_-_30783075 | 4.47 |
ENST00000215798.6
|
RNF215
|
ring finger protein 215 |
| chr8_-_27472198 | 4.46 |
ENST00000519472.1
ENST00000523589.1 ENST00000522413.1 ENST00000523396.1 ENST00000560366.1 |
CLU
|
clusterin |
| chr17_-_79633590 | 4.42 |
ENST00000374741.3
ENST00000571503.1 |
OXLD1
|
oxidoreductase-like domain containing 1 |
| chr4_-_141075330 | 4.32 |
ENST00000509479.2
|
MAML3
|
mastermind-like 3 (Drosophila) |
| chr12_-_49318715 | 4.23 |
ENST00000444214.2
|
FKBP11
|
FK506 binding protein 11, 19 kDa |
| chr1_+_153747746 | 4.22 |
ENST00000368661.3
|
SLC27A3
|
solute carrier family 27 (fatty acid transporter), member 3 |
| chr7_+_100199800 | 4.21 |
ENST00000223061.5
|
PCOLCE
|
procollagen C-endopeptidase enhancer |
| chr1_+_66458072 | 4.15 |
ENST00000423207.2
|
PDE4B
|
phosphodiesterase 4B, cAMP-specific |
| chr8_+_56014949 | 4.13 |
ENST00000327381.6
|
XKR4
|
XK, Kell blood group complex subunit-related family, member 4 |
| chr20_-_60942361 | 4.12 |
ENST00000252999.3
|
LAMA5
|
laminin, alpha 5 |
| chr1_+_10509971 | 4.09 |
ENST00000320498.4
|
CORT
|
cortistatin |
| chr17_+_6918354 | 4.08 |
ENST00000552775.1
|
C17orf49
|
chromosome 17 open reading frame 49 |
| chr7_-_156803329 | 4.06 |
ENST00000252971.6
|
MNX1
|
motor neuron and pancreas homeobox 1 |
| chr16_+_57844549 | 4.01 |
ENST00000564282.1
|
CTD-2600O9.1
|
uncharacterized protein LOC388282 |
| chrX_-_19140677 | 3.98 |
ENST00000357544.3
ENST00000379869.3 ENST00000360279.4 ENST00000379873.2 ENST00000379878.3 ENST00000354791.3 ENST00000379876.1 |
GPR64
|
G protein-coupled receptor 64 |
| chr20_+_33759854 | 3.96 |
ENST00000216968.4
|
PROCR
|
protein C receptor, endothelial |
| chr17_-_7760457 | 3.96 |
ENST00000576384.1
|
LSMD1
|
LSM domain containing 1 |
| chrX_-_119694538 | 3.96 |
ENST00000371322.5
|
CUL4B
|
cullin 4B |
| chr17_-_79166176 | 3.95 |
ENST00000571292.1
|
AZI1
|
5-azacytidine induced 1 |
| chr2_-_220436248 | 3.92 |
ENST00000265318.4
|
OBSL1
|
obscurin-like 1 |
| chr4_-_90229142 | 3.90 |
ENST00000609438.1
|
GPRIN3
|
GPRIN family member 3 |
| chr15_-_63674218 | 3.90 |
ENST00000178638.3
|
CA12
|
carbonic anhydrase XII |
| chr11_-_65325664 | 3.87 |
ENST00000301873.5
|
LTBP3
|
latent transforming growth factor beta binding protein 3 |
| chr12_+_20522179 | 3.86 |
ENST00000359062.3
|
PDE3A
|
phosphodiesterase 3A, cGMP-inhibited |
| chr20_+_4129496 | 3.85 |
ENST00000346595.2
|
SMOX
|
spermine oxidase |
| chr11_-_31531121 | 3.76 |
ENST00000532287.1
ENST00000526776.1 ENST00000534812.1 ENST00000529749.1 ENST00000278200.1 ENST00000530023.1 ENST00000533642.1 |
IMMP1L
|
IMP1 inner mitochondrial membrane peptidase-like (S. cerevisiae) |
| chr19_+_40877583 | 3.73 |
ENST00000596470.1
|
PLD3
|
phospholipase D family, member 3 |
| chr19_+_54385439 | 3.72 |
ENST00000536044.1
ENST00000540413.1 ENST00000263431.3 ENST00000419486.1 |
PRKCG
|
protein kinase C, gamma |
| chr1_-_21948906 | 3.69 |
ENST00000374761.2
ENST00000599760.1 |
RAP1GAP
|
RAP1 GTPase activating protein |
| chr16_+_691792 | 3.69 |
ENST00000307650.4
|
FAM195A
|
family with sequence similarity 195, member A |
| chrX_+_21392529 | 3.69 |
ENST00000425654.2
ENST00000543067.1 |
CNKSR2
|
connector enhancer of kinase suppressor of Ras 2 |
| chr3_+_110790590 | 3.62 |
ENST00000485303.1
|
PVRL3
|
poliovirus receptor-related 3 |
| chr22_-_30783356 | 3.62 |
ENST00000382363.3
|
RNF215
|
ring finger protein 215 |
| chr11_-_117747434 | 3.62 |
ENST00000529335.2
ENST00000530956.1 ENST00000260282.4 |
FXYD6
|
FXYD domain containing ion transport regulator 6 |
| chr16_-_31076332 | 3.61 |
ENST00000539836.3
ENST00000535577.1 ENST00000442862.2 |
ZNF668
|
zinc finger protein 668 |
| chr16_-_87367879 | 3.61 |
ENST00000568879.1
|
RP11-178L8.4
|
RP11-178L8.4 |
| chr15_+_73344791 | 3.56 |
ENST00000261908.6
|
NEO1
|
neogenin 1 |
| chrX_+_21392873 | 3.55 |
ENST00000379510.3
|
CNKSR2
|
connector enhancer of kinase suppressor of Ras 2 |
| chr2_-_220408260 | 3.55 |
ENST00000373891.2
|
CHPF
|
chondroitin polymerizing factor |
| chr7_-_95225768 | 3.50 |
ENST00000005178.5
|
PDK4
|
pyruvate dehydrogenase kinase, isozyme 4 |
| chr11_-_115375107 | 3.50 |
ENST00000545380.1
ENST00000452722.3 ENST00000537058.1 ENST00000536727.1 ENST00000542447.2 ENST00000331581.6 |
CADM1
|
cell adhesion molecule 1 |
| chr1_+_51434357 | 3.48 |
ENST00000396148.1
|
CDKN2C
|
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
| chr12_-_92539614 | 3.47 |
ENST00000256015.3
|
BTG1
|
B-cell translocation gene 1, anti-proliferative |
| chr10_-_64576105 | 3.46 |
ENST00000242480.3
ENST00000411732.1 |
EGR2
|
early growth response 2 |
| chr7_+_128828713 | 3.45 |
ENST00000249373.3
|
SMO
|
smoothened, frizzled family receptor |
| chr20_+_62367989 | 3.44 |
ENST00000309546.3
|
LIME1
|
Lck interacting transmembrane adaptor 1 |
| chr2_-_220083076 | 3.43 |
ENST00000295750.4
|
ABCB6
|
ATP-binding cassette, sub-family B (MDR/TAP), member 6 |
| chr19_+_35521699 | 3.43 |
ENST00000415950.3
|
SCN1B
|
sodium channel, voltage-gated, type I, beta subunit |
| chr1_+_231114795 | 3.41 |
ENST00000310256.2
ENST00000366658.2 ENST00000450711.1 ENST00000435927.1 |
ARV1
|
ARV1 homolog (S. cerevisiae) |
| chr7_+_128784712 | 3.40 |
ENST00000289407.4
|
TSPAN33
|
tetraspanin 33 |
| chr6_+_1312675 | 3.32 |
ENST00000296839.2
|
FOXQ1
|
forkhead box Q1 |
| chrX_+_47092314 | 3.31 |
ENST00000218348.3
|
USP11
|
ubiquitin specific peptidase 11 |
| chr16_+_230435 | 3.29 |
ENST00000199708.2
|
HBQ1
|
hemoglobin, theta 1 |
| chr11_-_66115032 | 3.29 |
ENST00000311181.4
|
B3GNT1
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1 |
| chr1_-_32229523 | 3.28 |
ENST00000398547.1
ENST00000373655.2 ENST00000373658.3 ENST00000257070.4 |
BAI2
|
brain-specific angiogenesis inhibitor 2 |
| chr14_-_27066960 | 3.28 |
ENST00000539517.2
|
NOVA1
|
neuro-oncological ventral antigen 1 |
| chr9_+_137533615 | 3.28 |
ENST00000371817.3
|
COL5A1
|
collagen, type V, alpha 1 |
| chr22_-_20307532 | 3.27 |
ENST00000405465.3
ENST00000248879.3 |
DGCR6L
|
DiGeorge syndrome critical region gene 6-like |
| chr17_-_19648916 | 3.27 |
ENST00000444455.1
ENST00000439102.2 |
ALDH3A1
|
aldehyde dehydrogenase 3 family, member A1 |
| chr11_-_117747607 | 3.26 |
ENST00000540359.1
ENST00000539526.1 |
FXYD6
|
FXYD domain containing ion transport regulator 6 |
| chr4_+_41540160 | 3.25 |
ENST00000503057.1
ENST00000511496.1 |
LIMCH1
|
LIM and calponin homology domains 1 |
| chr17_-_7760779 | 3.23 |
ENST00000335155.5
ENST00000575071.1 |
LSMD1
|
LSM domain containing 1 |
| chr7_-_27183263 | 3.21 |
ENST00000222726.3
|
HOXA5
|
homeobox A5 |
| chrX_+_46433193 | 3.18 |
ENST00000276055.3
|
CHST7
|
carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 7 |
| chr7_-_155604967 | 3.17 |
ENST00000297261.2
|
SHH
|
sonic hedgehog |
| chr2_-_7005785 | 3.16 |
ENST00000256722.5
ENST00000404168.1 ENST00000458098.1 |
CMPK2
|
cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial |
| chr17_+_68165657 | 3.15 |
ENST00000243457.3
|
KCNJ2
|
potassium inwardly-rectifying channel, subfamily J, member 2 |
| chr11_-_93276582 | 3.11 |
ENST00000298966.2
|
SMCO4
|
single-pass membrane protein with coiled-coil domains 4 |
| chr16_-_29910365 | 3.11 |
ENST00000346932.5
ENST00000350527.3 ENST00000537485.1 ENST00000568380.1 |
SEZ6L2
|
seizure related 6 homolog (mouse)-like 2 |
| chr17_+_7123207 | 3.10 |
ENST00000584103.1
ENST00000579886.2 |
ACADVL
|
acyl-CoA dehydrogenase, very long chain |
| chr1_+_155583012 | 3.06 |
ENST00000462250.2
|
MSTO1
|
misato 1, mitochondrial distribution and morphology regulator |
| chr10_+_89419370 | 3.05 |
ENST00000361175.4
ENST00000456849.1 |
PAPSS2
|
3'-phosphoadenosine 5'-phosphosulfate synthase 2 |
| chr2_+_73114489 | 3.00 |
ENST00000234454.5
|
SPR
|
sepiapterin reductase (7,8-dihydrobiopterin:NADP+ oxidoreductase) |
| chr19_+_42364460 | 3.00 |
ENST00000593863.1
|
RPS19
|
ribosomal protein S19 |
| chr15_+_99645277 | 2.99 |
ENST00000336292.6
ENST00000328642.7 |
SYNM
|
synemin, intermediate filament protein |
| chr5_+_174151536 | 2.98 |
ENST00000239243.6
ENST00000507785.1 |
MSX2
|
msh homeobox 2 |
| chr2_+_219724544 | 2.96 |
ENST00000233948.3
|
WNT6
|
wingless-type MMTV integration site family, member 6 |
| chr8_-_62627057 | 2.96 |
ENST00000519234.1
ENST00000379449.6 ENST00000379454.4 ENST00000518068.1 ENST00000517856.1 ENST00000356457.5 |
ASPH
|
aspartate beta-hydroxylase |
| chr3_+_110790715 | 2.95 |
ENST00000319792.3
|
PVRL3
|
poliovirus receptor-related 3 |
| chr19_+_51153045 | 2.95 |
ENST00000458538.1
|
C19orf81
|
chromosome 19 open reading frame 81 |
| chr16_-_57837129 | 2.94 |
ENST00000562984.1
ENST00000564891.1 |
KIFC3
|
kinesin family member C3 |
| chr14_+_24521202 | 2.94 |
ENST00000334420.7
ENST00000342740.5 |
LRRC16B
|
leucine rich repeat containing 16B |
| chr19_-_51014588 | 2.93 |
ENST00000598418.1
|
JOSD2
|
Josephin domain containing 2 |
| chr11_-_67120974 | 2.90 |
ENST00000539074.1
ENST00000312419.3 |
POLD4
|
polymerase (DNA-directed), delta 4, accessory subunit |
| chr16_-_776431 | 2.88 |
ENST00000293889.6
|
CCDC78
|
coiled-coil domain containing 78 |
| chr4_-_39640513 | 2.88 |
ENST00000511809.1
ENST00000505729.1 |
SMIM14
|
small integral membrane protein 14 |
| chr6_-_76203454 | 2.87 |
ENST00000237172.7
|
FILIP1
|
filamin A interacting protein 1 |
| chr13_-_110438914 | 2.85 |
ENST00000375856.3
|
IRS2
|
insulin receptor substrate 2 |
| chr21_+_47531328 | 2.85 |
ENST00000409416.1
ENST00000397763.1 |
COL6A2
|
collagen, type VI, alpha 2 |
| chr19_-_51014460 | 2.84 |
ENST00000595669.1
|
JOSD2
|
Josephin domain containing 2 |
| chr12_-_49319265 | 2.82 |
ENST00000552878.1
ENST00000453172.2 |
FKBP11
|
FK506 binding protein 11, 19 kDa |
| chrX_-_19140575 | 2.80 |
ENST00000357991.3
ENST00000356606.4 |
GPR64
|
G protein-coupled receptor 64 |
| chr7_+_99971068 | 2.76 |
ENST00000198536.2
ENST00000453419.1 |
PILRA
|
paired immunoglobin-like type 2 receptor alpha |
| chr17_+_26369865 | 2.75 |
ENST00000582037.1
|
NLK
|
nemo-like kinase |
| chr11_-_63933504 | 2.73 |
ENST00000255681.6
|
MACROD1
|
MACRO domain containing 1 |
| chrX_-_110513703 | 2.71 |
ENST00000324068.1
|
CAPN6
|
calpain 6 |
| chrX_+_117629766 | 2.70 |
ENST00000276204.6
ENST00000276202.7 |
DOCK11
|
dedicator of cytokinesis 11 |
| chr16_+_2285817 | 2.66 |
ENST00000564065.1
|
DNASE1L2
|
deoxyribonuclease I-like 2 |
| chr17_+_39411636 | 2.64 |
ENST00000394008.1
|
KRTAP9-9
|
keratin associated protein 9-9 |
| chr1_-_92351769 | 2.64 |
ENST00000212355.4
|
TGFBR3
|
transforming growth factor, beta receptor III |
| chr10_-_73848531 | 2.64 |
ENST00000373109.2
|
SPOCK2
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
| chr1_-_53793584 | 2.64 |
ENST00000354412.3
ENST00000347547.2 ENST00000306052.6 |
LRP8
|
low density lipoprotein receptor-related protein 8, apolipoprotein e receptor |
| chr17_+_73512594 | 2.63 |
ENST00000333213.6
|
TSEN54
|
TSEN54 tRNA splicing endonuclease subunit |
| chr6_-_76203345 | 2.63 |
ENST00000393004.2
|
FILIP1
|
filamin A interacting protein 1 |
| chr7_-_94285472 | 2.63 |
ENST00000437425.2
ENST00000447873.1 ENST00000415788.2 |
SGCE
|
sarcoglycan, epsilon |
| chr12_+_54410664 | 2.63 |
ENST00000303406.4
|
HOXC4
|
homeobox C4 |
| chr14_-_23284703 | 2.62 |
ENST00000555911.1
|
SLC7A7
|
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
| chr3_-_186080012 | 2.62 |
ENST00000544847.1
ENST00000265022.3 |
DGKG
|
diacylglycerol kinase, gamma 90kDa |
| chr7_-_94285511 | 2.61 |
ENST00000265735.7
|
SGCE
|
sarcoglycan, epsilon |
| chr5_+_139027877 | 2.60 |
ENST00000302517.3
|
CXXC5
|
CXXC finger protein 5 |
| chr19_+_54695098 | 2.58 |
ENST00000396388.2
|
TSEN34
|
TSEN34 tRNA splicing endonuclease subunit |
| chr4_-_140223614 | 2.58 |
ENST00000394223.1
|
NDUFC1
|
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 1, 6kDa |
| chr15_+_41221536 | 2.56 |
ENST00000249749.5
|
DLL4
|
delta-like 4 (Drosophila) |
| chr11_+_77300669 | 2.54 |
ENST00000313578.3
|
AQP11
|
aquaporin 11 |
| chrX_-_53350522 | 2.54 |
ENST00000396435.3
ENST00000375368.5 |
IQSEC2
|
IQ motif and Sec7 domain 2 |
| chr4_-_101111615 | 2.53 |
ENST00000273990.2
|
DDIT4L
|
DNA-damage-inducible transcript 4-like |
| chr12_+_58335360 | 2.52 |
ENST00000300145.3
|
XRCC6BP1
|
XRCC6 binding protein 1 |
| chr19_-_44174330 | 2.51 |
ENST00000340093.3
|
PLAUR
|
plasminogen activator, urokinase receptor |
| chr9_-_139581848 | 2.50 |
ENST00000538402.1
ENST00000371694.3 |
AGPAT2
|
1-acylglycerol-3-phosphate O-acyltransferase 2 |
| chr3_+_49058444 | 2.49 |
ENST00000326925.6
ENST00000395458.2 |
NDUFAF3
|
NADH dehydrogenase (ubiquinone) complex I, assembly factor 3 |
| chr11_-_14913765 | 2.48 |
ENST00000334636.5
|
CYP2R1
|
cytochrome P450, family 2, subfamily R, polypeptide 1 |
| chrX_+_153060090 | 2.48 |
ENST00000370086.3
ENST00000370085.3 |
SSR4
|
signal sequence receptor, delta |
| chr19_-_39402798 | 2.48 |
ENST00000571838.1
|
CTC-360G5.1
|
coiled-coil glutamate-rich protein 2 |
| chr19_+_35759824 | 2.47 |
ENST00000343550.5
|
USF2
|
upstream transcription factor 2, c-fos interacting |
| chr11_+_48002076 | 2.47 |
ENST00000418331.2
ENST00000440289.2 |
PTPRJ
|
protein tyrosine phosphatase, receptor type, J |
| chr1_+_6086380 | 2.46 |
ENST00000602612.1
ENST00000378087.3 ENST00000341524.1 ENST00000352527.1 |
KCNAB2
|
potassium voltage-gated channel, shaker-related subfamily, beta member 2 |
| chr2_+_220408724 | 2.45 |
ENST00000421791.1
ENST00000373883.3 ENST00000451952.1 |
TMEM198
|
transmembrane protein 198 |
| chr1_-_11918988 | 2.44 |
ENST00000376468.3
|
NPPB
|
natriuretic peptide B |
| chr9_-_139581875 | 2.43 |
ENST00000371696.2
|
AGPAT2
|
1-acylglycerol-3-phosphate O-acyltransferase 2 |
| chr2_-_148779106 | 2.43 |
ENST00000416719.1
ENST00000264169.2 |
ORC4
|
origin recognition complex, subunit 4 |
| chr11_+_68080077 | 2.43 |
ENST00000294304.7
|
LRP5
|
low density lipoprotein receptor-related protein 5 |
| chr20_-_31071239 | 2.42 |
ENST00000359676.5
|
C20orf112
|
chromosome 20 open reading frame 112 |
| chr6_-_32122106 | 2.42 |
ENST00000428778.1
|
PRRT1
|
proline-rich transmembrane protein 1 |
| chr3_-_155394099 | 2.40 |
ENST00000414191.1
|
PLCH1
|
phospholipase C, eta 1 |
| chr8_+_145438870 | 2.40 |
ENST00000527931.1
|
FAM203B
|
family with sequence similarity 203, member B |
| chr22_-_50964849 | 2.39 |
ENST00000543927.1
ENST00000423348.1 |
SCO2
|
SCO2 cytochrome c oxidase assembly protein |
| chr4_+_15004165 | 2.39 |
ENST00000538197.1
ENST00000541112.1 ENST00000442003.2 |
CPEB2
|
cytoplasmic polyadenylation element binding protein 2 |
| chr12_-_125348329 | 2.39 |
ENST00000546215.1
ENST00000415380.2 ENST00000261693.6 ENST00000376788.1 ENST00000545493.1 |
SCARB1
|
scavenger receptor class B, member 1 |
| chr15_-_74501360 | 2.38 |
ENST00000323940.5
|
STRA6
|
stimulated by retinoic acid 6 |
Network of associatons between targets according to the STRING database.
First level regulatory network of MYF6
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.7 | 14.2 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 4.4 | 17.5 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
| 3.7 | 14.9 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
| 2.1 | 8.3 | GO:0019056 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
| 1.6 | 7.9 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
| 1.6 | 3.1 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
| 1.5 | 17.5 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
| 1.4 | 4.2 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
| 1.4 | 8.3 | GO:1902462 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 1.3 | 6.6 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
| 1.3 | 5.2 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 1.2 | 3.7 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
| 1.2 | 8.6 | GO:0046208 | spermine catabolic process(GO:0046208) |
| 1.2 | 3.6 | GO:1904397 | negative regulation of neuromuscular junction development(GO:1904397) |
| 1.2 | 4.6 | GO:0003335 | corneocyte development(GO:0003335) |
| 1.2 | 3.5 | GO:0035284 | rhombomere 3 development(GO:0021569) rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 1.1 | 3.3 | GO:0035989 | tendon development(GO:0035989) |
| 1.0 | 4.2 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 1.0 | 4.2 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
| 1.0 | 10.3 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 1.0 | 9.3 | GO:0021842 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
| 1.0 | 3.0 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
| 1.0 | 5.0 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 1.0 | 3.0 | GO:0051795 | positive regulation of catagen(GO:0051795) activation of meiosis(GO:0090427) |
| 0.9 | 2.8 | GO:0006173 | dADP biosynthetic process(GO:0006173) |
| 0.9 | 4.6 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
| 0.9 | 6.4 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
| 0.9 | 8.9 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
| 0.9 | 3.6 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
| 0.8 | 5.1 | GO:0072069 | ascending thin limb development(GO:0072021) DCT cell differentiation(GO:0072069) metanephric ascending thin limb development(GO:0072218) metanephric DCT cell differentiation(GO:0072240) |
| 0.8 | 10.1 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
| 0.8 | 2.5 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
| 0.8 | 3.3 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
| 0.8 | 3.2 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
| 0.8 | 5.5 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.8 | 3.2 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
| 0.8 | 3.2 | GO:0002182 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
| 0.8 | 15.6 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
| 0.8 | 4.7 | GO:0061143 | alveolar primary septum development(GO:0061143) |
| 0.8 | 3.1 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 0.8 | 11.3 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.8 | 5.3 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.7 | 3.0 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
| 0.7 | 0.7 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
| 0.7 | 9.3 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
| 0.7 | 10.5 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.7 | 3.4 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 0.7 | 2.0 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
| 0.7 | 2.0 | GO:0061110 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
| 0.6 | 3.9 | GO:0071321 | cellular response to cGMP(GO:0071321) |
| 0.6 | 12.8 | GO:0071420 | cellular response to histamine(GO:0071420) |
| 0.6 | 5.7 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
| 0.6 | 1.8 | GO:0044209 | AMP salvage(GO:0044209) |
| 0.6 | 9.0 | GO:1901898 | negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.6 | 1.8 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) positive regulation of somatostatin secretion(GO:0090274) |
| 0.6 | 2.9 | GO:0032425 | positive regulation of mismatch repair(GO:0032425) |
| 0.6 | 3.5 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.6 | 2.3 | GO:0070846 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.6 | 4.5 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.5 | 3.3 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 0.5 | 3.2 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 0.5 | 9.4 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.5 | 2.5 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
| 0.5 | 1.5 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
| 0.5 | 3.0 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
| 0.5 | 2.9 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.5 | 4.3 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
| 0.5 | 0.9 | GO:1990051 | activation of protein kinase C activity(GO:1990051) |
| 0.5 | 3.2 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
| 0.5 | 5.9 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.5 | 1.4 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
| 0.4 | 9.3 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.4 | 2.6 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
| 0.4 | 1.3 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.4 | 1.7 | GO:0006238 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.4 | 3.8 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.4 | 1.2 | GO:0019516 | lactate oxidation(GO:0019516) |
| 0.4 | 1.2 | GO:1900369 | transcription, RNA-templated(GO:0001172) negative regulation of RNA interference(GO:1900369) |
| 0.4 | 3.5 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.4 | 5.6 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.4 | 7.0 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 0.4 | 0.4 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
| 0.4 | 2.2 | GO:0097490 | sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
| 0.4 | 1.1 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
| 0.4 | 2.2 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
| 0.4 | 1.4 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
| 0.4 | 2.5 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 0.4 | 1.4 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
| 0.3 | 4.5 | GO:0015911 | plasma membrane long-chain fatty acid transport(GO:0015911) |
| 0.3 | 1.0 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
| 0.3 | 2.7 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.3 | 1.3 | GO:0050960 | detection of temperature stimulus involved in thermoception(GO:0050960) response to capsazepine(GO:1901594) |
| 0.3 | 5.9 | GO:0030238 | male sex determination(GO:0030238) |
| 0.3 | 2.9 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.3 | 0.3 | GO:0000429 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) |
| 0.3 | 4.1 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.3 | 4.0 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
| 0.3 | 1.2 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
| 0.3 | 2.9 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.3 | 1.2 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
| 0.3 | 0.9 | GO:0002590 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) positive regulation of iron ion transport(GO:0034758) positive regulation of iron ion transmembrane transport(GO:0034761) regulation of iron ion import(GO:1900390) regulation of ferrous iron import into cell(GO:1903989) positive regulation of ferrous iron import into cell(GO:1903991) regulation of ferrous iron binding(GO:1904432) positive regulation of ferrous iron binding(GO:1904434) regulation of transferrin receptor binding(GO:1904435) positive regulation of transferrin receptor binding(GO:1904437) regulation of ferrous iron import across plasma membrane(GO:1904438) positive regulation of ferrous iron import across plasma membrane(GO:1904440) response to iron ion starvation(GO:1990641) |
| 0.3 | 7.8 | GO:0035493 | SNARE complex assembly(GO:0035493) |
| 0.3 | 1.1 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.3 | 1.4 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
| 0.3 | 1.7 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.3 | 3.1 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.3 | 4.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.3 | 2.5 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.3 | 3.0 | GO:0046146 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.3 | 9.8 | GO:0002076 | osteoblast development(GO:0002076) |
| 0.3 | 0.8 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 0.3 | 2.2 | GO:0040038 | polar body extrusion after meiotic divisions(GO:0040038) formin-nucleated actin cable assembly(GO:0070649) |
| 0.3 | 1.6 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 0.3 | 1.0 | GO:0017157 | regulation of exocytosis(GO:0017157) |
| 0.3 | 4.7 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.3 | 0.8 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
| 0.3 | 1.0 | GO:0005997 | xylulose metabolic process(GO:0005997) glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.2 | 11.7 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.2 | 0.7 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
| 0.2 | 3.1 | GO:2000680 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 0.2 | 0.7 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
| 0.2 | 1.4 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 0.2 | 1.8 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 0.2 | 5.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.2 | 0.2 | GO:2000981 | negative regulation of mechanoreceptor differentiation(GO:0045632) negative regulation of pro-B cell differentiation(GO:2000974) negative regulation of inner ear receptor cell differentiation(GO:2000981) |
| 0.2 | 1.4 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 0.2 | 0.9 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.2 | 1.3 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 0.2 | 0.2 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
| 0.2 | 1.1 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.2 | 1.8 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 0.2 | 27.2 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
| 0.2 | 1.1 | GO:0015862 | uridine transport(GO:0015862) |
| 0.2 | 1.0 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
| 0.2 | 3.7 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
| 0.2 | 4.9 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 0.2 | 2.2 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.2 | 0.8 | GO:0061743 | motor learning(GO:0061743) |
| 0.2 | 8.1 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.2 | 4.5 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
| 0.2 | 0.2 | GO:0071504 | cellular response to heparin(GO:0071504) |
| 0.2 | 0.8 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
| 0.2 | 1.4 | GO:0048105 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 0.2 | 1.7 | GO:0007163 | establishment or maintenance of cell polarity(GO:0007163) |
| 0.2 | 0.8 | GO:1902532 | negative regulation of intracellular signal transduction(GO:1902532) |
| 0.2 | 0.6 | GO:0008272 | sulfate transport(GO:0008272) |
| 0.2 | 1.1 | GO:0021539 | subthalamus development(GO:0021539) |
| 0.2 | 6.0 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.2 | 4.0 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
| 0.2 | 3.8 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.2 | 3.6 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
| 0.2 | 1.1 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.2 | 4.1 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.2 | 1.3 | GO:0001550 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 0.2 | 1.7 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.2 | 1.3 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
| 0.2 | 3.4 | GO:0015886 | heme transport(GO:0015886) |
| 0.2 | 2.1 | GO:0032456 | endocytic recycling(GO:0032456) |
| 0.2 | 6.4 | GO:0006198 | cAMP catabolic process(GO:0006198) |
| 0.2 | 1.2 | GO:0015798 | myo-inositol transport(GO:0015798) |
| 0.2 | 3.7 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
| 0.2 | 4.4 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.2 | 1.6 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) |
| 0.2 | 0.2 | GO:0002339 | B cell selection(GO:0002339) |
| 0.2 | 0.7 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
| 0.2 | 1.2 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.2 | 0.5 | GO:0051714 | negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) regulation of cytolysis in other organism(GO:0051710) positive regulation of cytolysis in other organism(GO:0051714) |
| 0.2 | 1.9 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.2 | 4.7 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
| 0.2 | 1.5 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.2 | 2.0 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
| 0.2 | 1.5 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) insulin metabolic process(GO:1901142) |
| 0.2 | 3.2 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
| 0.2 | 1.9 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.2 | 14.7 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
| 0.2 | 4.1 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.2 | 3.3 | GO:0015671 | oxygen transport(GO:0015671) |
| 0.2 | 1.5 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
| 0.1 | 2.7 | GO:0060242 | contact inhibition(GO:0060242) |
| 0.1 | 1.6 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.1 | 0.7 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
| 0.1 | 1.0 | GO:0060296 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 0.1 | 3.1 | GO:0048311 | mitochondrion distribution(GO:0048311) |
| 0.1 | 1.7 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.1 | 0.9 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
| 0.1 | 0.7 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.1 | 0.7 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.1 | 0.4 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 0.1 | 2.4 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
| 0.1 | 0.6 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
| 0.1 | 2.6 | GO:0048562 | embryonic organ morphogenesis(GO:0048562) |
| 0.1 | 2.8 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
| 0.1 | 0.4 | GO:0072720 | cellular response to mycotoxin(GO:0036146) response to dithiothreitol(GO:0072720) |
| 0.1 | 1.3 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
| 0.1 | 0.9 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.1 | 1.3 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
| 0.1 | 0.3 | GO:0003051 | angiotensin-mediated drinking behavior(GO:0003051) |
| 0.1 | 2.3 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.1 | 0.6 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.1 | 0.8 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.1 | 0.8 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
| 0.1 | 1.3 | GO:0021527 | ventral spinal cord interneuron differentiation(GO:0021514) spinal cord association neuron differentiation(GO:0021527) |
| 0.1 | 0.5 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.1 | 2.7 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.1 | 0.7 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
| 0.1 | 1.0 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 0.1 | 0.8 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
| 0.1 | 1.5 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
| 0.1 | 3.4 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.1 | 1.9 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.1 | 1.3 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
| 0.1 | 0.2 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 0.1 | 0.5 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
| 0.1 | 0.5 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
| 0.1 | 2.1 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.1 | 1.3 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.1 | 0.6 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.1 | 0.5 | GO:0001757 | somite specification(GO:0001757) |
| 0.1 | 1.1 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.1 | 1.3 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.1 | 0.7 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
| 0.1 | 0.9 | GO:0006406 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
| 0.1 | 2.8 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
| 0.1 | 1.4 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.1 | 1.5 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.1 | 0.9 | GO:0070987 | error-free translesion synthesis(GO:0070987) |
| 0.1 | 1.4 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) |
| 0.1 | 1.2 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
| 0.1 | 3.1 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 0.1 | 3.3 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
| 0.1 | 3.4 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.1 | 1.6 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
| 0.1 | 0.4 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
| 0.1 | 1.4 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.1 | 3.3 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.1 | 0.2 | GO:0071613 | granzyme B production(GO:0071613) regulation of granzyme B production(GO:0071661) positive regulation of granzyme B production(GO:0071663) |
| 0.1 | 4.9 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.1 | 1.3 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
| 0.1 | 1.8 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.1 | 0.5 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.1 | 0.3 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
| 0.1 | 0.5 | GO:0097350 | neutrophil clearance(GO:0097350) |
| 0.1 | 0.3 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.1 | 0.2 | GO:0002519 | natural killer cell tolerance induction(GO:0002519) negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) |
| 0.1 | 8.2 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.1 | 0.9 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.1 | 1.1 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 0.1 | 0.7 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 0.1 | 1.5 | GO:0045475 | locomotor rhythm(GO:0045475) |
| 0.1 | 0.4 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
| 0.1 | 0.7 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
| 0.1 | 8.9 | GO:0006081 | cellular aldehyde metabolic process(GO:0006081) |
| 0.1 | 0.4 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.1 | 0.9 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.1 | 0.4 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
| 0.1 | 1.3 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.1 | 0.5 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.1 | 0.5 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
| 0.1 | 1.5 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.1 | 1.0 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.1 | 0.5 | GO:0007638 | mechanosensory behavior(GO:0007638) |
| 0.1 | 2.4 | GO:0009607 | response to biotic stimulus(GO:0009607) |
| 0.1 | 0.5 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.1 | 1.3 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.1 | 0.1 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
| 0.1 | 0.4 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.1 | 0.9 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.1 | 2.9 | GO:0001755 | neural crest cell migration(GO:0001755) |
| 0.1 | 2.4 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
| 0.1 | 2.0 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
| 0.1 | 0.6 | GO:0042426 | choline catabolic process(GO:0042426) |
| 0.1 | 1.4 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.1 | 2.1 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
| 0.1 | 0.3 | GO:0048539 | bone marrow development(GO:0048539) |
| 0.1 | 1.0 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
| 0.1 | 1.2 | GO:1900120 | regulation of receptor binding(GO:1900120) |
| 0.1 | 0.3 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
| 0.1 | 1.0 | GO:0010002 | cardioblast differentiation(GO:0010002) |
| 0.1 | 0.8 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
| 0.1 | 0.6 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
| 0.1 | 3.0 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
| 0.1 | 0.3 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
| 0.1 | 7.1 | GO:0050880 | regulation of blood vessel size(GO:0050880) |
| 0.1 | 4.5 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
| 0.1 | 1.9 | GO:0031063 | regulation of histone deacetylation(GO:0031063) |
| 0.1 | 3.9 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 0.1 | 2.5 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.1 | 4.3 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
| 0.1 | 0.2 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
| 0.1 | 0.6 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
| 0.1 | 0.4 | GO:0046851 | negative regulation of bone resorption(GO:0045779) negative regulation of bone remodeling(GO:0046851) |
| 0.1 | 1.3 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
| 0.0 | 2.0 | GO:0090383 | phagosome acidification(GO:0090383) |
| 0.0 | 0.9 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
| 0.0 | 0.7 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.0 | 0.2 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
| 0.0 | 0.4 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
| 0.0 | 1.1 | GO:0007220 | Notch receptor processing(GO:0007220) |
| 0.0 | 0.2 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
| 0.0 | 0.4 | GO:0048625 | myoblast fate commitment(GO:0048625) |
| 0.0 | 0.7 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.0 | 0.2 | GO:1903998 | regulation of eating behavior(GO:1903998) |
| 0.0 | 2.7 | GO:0060612 | adipose tissue development(GO:0060612) |
| 0.0 | 0.9 | GO:0008589 | regulation of smoothened signaling pathway(GO:0008589) |
| 0.0 | 0.3 | GO:2000352 | negative regulation of endothelial cell apoptotic process(GO:2000352) |
| 0.0 | 0.6 | GO:0042355 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.0 | 0.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.0 | 0.3 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
| 0.0 | 0.7 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
| 0.0 | 0.7 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
| 0.0 | 0.6 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.0 | 0.6 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
| 0.0 | 1.3 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.0 | 0.5 | GO:0060539 | diaphragm development(GO:0060539) |
| 0.0 | 0.7 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 0.0 | 0.1 | GO:0051459 | regulation of corticotropin secretion(GO:0051459) cellular response to cocaine(GO:0071314) |
| 0.0 | 0.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 0.0 | 1.6 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.0 | 0.5 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.0 | 4.2 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
| 0.0 | 0.5 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
| 0.0 | 0.2 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.0 | 0.4 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
| 0.0 | 1.5 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.0 | 0.2 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.0 | 0.5 | GO:0071897 | DNA biosynthetic process(GO:0071897) |
| 0.0 | 0.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.0 | 2.2 | GO:0043966 | histone H3 acetylation(GO:0043966) |
| 0.0 | 0.6 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.0 | 0.5 | GO:0097050 | type B pancreatic cell apoptotic process(GO:0097050) regulation of type B pancreatic cell apoptotic process(GO:2000674) |
| 0.0 | 1.0 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
| 0.0 | 2.5 | GO:0006511 | ubiquitin-dependent protein catabolic process(GO:0006511) |
| 0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.0 | 0.6 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.0 | 1.2 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.0 | 0.6 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.0 | 0.7 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.0 | 0.4 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.0 | 1.2 | GO:0050427 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.0 | 0.8 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.0 | 1.0 | GO:0021772 | olfactory bulb development(GO:0021772) |
| 0.0 | 2.7 | GO:0001578 | microtubule bundle formation(GO:0001578) |
| 0.0 | 0.2 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
| 0.0 | 0.2 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.0 | 0.2 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) initiation of neural tube closure(GO:0021993) |
| 0.0 | 2.6 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 0.0 | 1.2 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
| 0.0 | 0.9 | GO:0015698 | inorganic anion transport(GO:0015698) |
| 0.0 | 4.0 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
| 0.0 | 0.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.0 | 0.2 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
| 0.0 | 0.1 | GO:0023061 | signal release(GO:0023061) |
| 0.0 | 0.1 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 0.0 | 2.6 | GO:0032418 | lysosome localization(GO:0032418) |
| 0.0 | 0.4 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.0 | 0.4 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
| 0.0 | 1.1 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.0 | 0.3 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.0 | 1.2 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
| 0.0 | 2.1 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
| 0.0 | 0.1 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
| 0.0 | 0.1 | GO:0043129 | surfactant homeostasis(GO:0043129) |
| 0.0 | 0.5 | GO:0035690 | cellular response to drug(GO:0035690) |
| 0.0 | 0.3 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.0 | 2.5 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 0.0 | 0.5 | GO:0008089 | anterograde axonal transport(GO:0008089) |
| 0.0 | 0.5 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.0 | 0.1 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
| 0.0 | 0.4 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
| 0.0 | 0.2 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.0 | 3.3 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
| 0.0 | 0.5 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
| 0.0 | 0.4 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.0 | 1.5 | GO:0044070 | regulation of anion transport(GO:0044070) |
| 0.0 | 2.6 | GO:0090263 | positive regulation of canonical Wnt signaling pathway(GO:0090263) |
| 0.0 | 0.2 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.0 | 0.7 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
| 0.0 | 0.7 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
| 0.0 | 0.1 | GO:0006836 | neurotransmitter transport(GO:0006836) |
| 0.0 | 0.9 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
| 0.0 | 0.5 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
| 0.0 | 0.6 | GO:0050779 | RNA destabilization(GO:0050779) |
| 0.0 | 0.1 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) regulation of pigment cell differentiation(GO:0050932) |
| 0.0 | 0.5 | GO:0006974 | cellular response to DNA damage stimulus(GO:0006974) |
| 0.0 | 0.6 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
| 0.0 | 0.1 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.0 | 1.5 | GO:0007219 | Notch signaling pathway(GO:0007219) |
| 0.0 | 0.4 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
| 0.0 | 0.3 | GO:0043524 | negative regulation of neuron apoptotic process(GO:0043524) |
| 0.0 | 0.1 | GO:0006937 | regulation of muscle contraction(GO:0006937) |
| 0.0 | 0.3 | GO:0051352 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
| 0.0 | 0.0 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
| 0.0 | 0.3 | GO:0045638 | negative regulation of myeloid cell differentiation(GO:0045638) |
| 0.0 | 0.1 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.0 | 0.2 | GO:0048854 | brain morphogenesis(GO:0048854) |
| 0.0 | 0.5 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
| 0.0 | 0.1 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.0 | 0.5 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
| 0.0 | 0.2 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
| 0.0 | 0.3 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
| 0.0 | 0.5 | GO:0051926 | negative regulation of calcium ion transport(GO:0051926) |
| 0.0 | 0.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.0 | 0.3 | GO:0043462 | regulation of ATPase activity(GO:0043462) |
| 0.0 | 0.7 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.0 | 0.0 | GO:1900107 | regulation of nodal signaling pathway(GO:1900107) |
| 0.0 | 0.4 | GO:0006308 | DNA catabolic process(GO:0006308) |
| 0.0 | 0.2 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
| 0.0 | 0.2 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.9 | 16.8 | GO:0035976 | AP1 complex(GO:0035976) |
| 1.4 | 4.1 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
| 1.3 | 3.8 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 1.2 | 9.2 | GO:1990393 | 3M complex(GO:1990393) |
| 1.1 | 3.3 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 1.0 | 5.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.7 | 3.6 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
| 0.7 | 3.4 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
| 0.7 | 7.6 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.7 | 2.7 | GO:0060187 | cell pole(GO:0060187) |
| 0.7 | 2.0 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
| 0.6 | 14.9 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.6 | 3.2 | GO:0043260 | laminin-11 complex(GO:0043260) |
| 0.6 | 15.6 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.6 | 3.0 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
| 0.5 | 15.6 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
| 0.5 | 2.5 | GO:1990031 | pinceau fiber(GO:1990031) |
| 0.5 | 2.4 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 0.5 | 2.9 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.4 | 4.3 | GO:0016012 | sarcoglycan complex(GO:0016012) |
| 0.4 | 4.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.4 | 2.9 | GO:0098536 | deuterosome(GO:0098536) |
| 0.4 | 5.9 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 0.4 | 1.2 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
| 0.4 | 2.6 | GO:0045298 | tubulin complex(GO:0045298) |
| 0.4 | 3.3 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
| 0.4 | 1.4 | GO:0005916 | fascia adherens(GO:0005916) |
| 0.4 | 2.5 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 0.3 | 2.3 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.3 | 4.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.3 | 5.1 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.3 | 3.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.3 | 1.5 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 0.3 | 4.5 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) chromaffin granule(GO:0042583) |
| 0.2 | 4.1 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.2 | 1.7 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
| 0.2 | 3.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.2 | 3.1 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
| 0.2 | 3.7 | GO:0097060 | synaptic membrane(GO:0097060) |
| 0.2 | 2.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.2 | 1.6 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 0.2 | 0.8 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.2 | 0.6 | GO:0070703 | inner mucus layer(GO:0070702) outer mucus layer(GO:0070703) |
| 0.2 | 0.5 | GO:0005745 | m-AAA complex(GO:0005745) |
| 0.2 | 2.0 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.2 | 3.4 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
| 0.2 | 0.3 | GO:0005927 | muscle tendon junction(GO:0005927) |
| 0.2 | 1.0 | GO:0005594 | collagen type IX trimer(GO:0005594) |
| 0.2 | 0.6 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
| 0.2 | 2.2 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.1 | 14.6 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.1 | 1.5 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 0.1 | 1.7 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 0.1 | 2.2 | GO:0071438 | invadopodium membrane(GO:0071438) |
| 0.1 | 1.0 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
| 0.1 | 0.4 | GO:0018444 | translation release factor complex(GO:0018444) |
| 0.1 | 4.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.1 | 1.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
| 0.1 | 0.7 | GO:0034680 | integrin alpha10-beta1 complex(GO:0034680) |
| 0.1 | 0.7 | GO:0032437 | cuticular plate(GO:0032437) |
| 0.1 | 6.2 | GO:0030673 | axolemma(GO:0030673) |
| 0.1 | 9.4 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.1 | 2.9 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.1 | 1.4 | GO:0072487 | MSL complex(GO:0072487) |
| 0.1 | 1.0 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
| 0.1 | 1.1 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.1 | 1.0 | GO:0005638 | lamin filament(GO:0005638) |
| 0.1 | 1.9 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.1 | 2.6 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 0.1 | 13.2 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.1 | 0.7 | GO:0001652 | granular component(GO:0001652) |
| 0.1 | 0.6 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 0.1 | 2.1 | GO:0000812 | Swr1 complex(GO:0000812) |
| 0.1 | 1.4 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.1 | 25.7 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
| 0.1 | 0.4 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
| 0.1 | 14.4 | GO:0043204 | perikaryon(GO:0043204) |
| 0.1 | 1.6 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.1 | 5.1 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.1 | 1.0 | GO:0060091 | kinocilium(GO:0060091) |
| 0.1 | 1.3 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.1 | 1.1 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
| 0.1 | 0.4 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 0.1 | 4.5 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 0.1 | 0.2 | GO:0034455 | t-UTP complex(GO:0034455) |
| 0.1 | 0.5 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 0.1 | 0.5 | GO:0019815 | B cell receptor complex(GO:0019815) |
| 0.1 | 0.9 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.1 | 0.3 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
| 0.1 | 4.2 | GO:0097542 | ciliary tip(GO:0097542) |
| 0.1 | 2.8 | GO:0000145 | exocyst(GO:0000145) |
| 0.1 | 0.8 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
| 0.1 | 1.7 | GO:0019814 | immunoglobulin complex(GO:0019814) |
| 0.1 | 0.5 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.1 | 1.7 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
| 0.1 | 4.4 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
| 0.1 | 1.6 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
| 0.1 | 1.5 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.1 | 0.8 | GO:0033269 | internode region of axon(GO:0033269) |
| 0.1 | 1.0 | GO:0030126 | COPI vesicle coat(GO:0030126) |
| 0.1 | 0.3 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.1 | 0.6 | GO:0005688 | U6 snRNP(GO:0005688) |
| 0.1 | 1.0 | GO:0031045 | dense core granule(GO:0031045) |
| 0.1 | 1.4 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.1 | 5.0 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.0 | 1.1 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 0.0 | 0.7 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
| 0.0 | 1.3 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.0 | 4.1 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
| 0.0 | 0.5 | GO:0031906 | late endosome lumen(GO:0031906) |
| 0.0 | 5.4 | GO:0045211 | postsynaptic membrane(GO:0045211) |
| 0.0 | 3.1 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 0.0 | 28.7 | GO:0031966 | mitochondrial membrane(GO:0031966) |
| 0.0 | 3.0 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.0 | 0.6 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.0 | 2.0 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.0 | 1.7 | GO:0016324 | apical plasma membrane(GO:0016324) |
| 0.0 | 5.2 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.0 | 0.6 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.0 | 7.3 | GO:0001650 | fibrillar center(GO:0001650) |
| 0.0 | 0.2 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
| 0.0 | 2.8 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
| 0.0 | 0.9 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.0 | 0.8 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.0 | 1.4 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.0 | 1.3 | GO:0016592 | mediator complex(GO:0016592) |
| 0.0 | 0.6 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 0.0 | 2.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.0 | 2.0 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.0 | 1.1 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.0 | 0.7 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.0 | 0.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.0 | 1.8 | GO:0036064 | ciliary basal body(GO:0036064) |
| 0.0 | 0.1 | GO:0032280 | symmetric synapse(GO:0032280) |
| 0.0 | 1.5 | GO:0031672 | A band(GO:0031672) |
| 0.0 | 0.2 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
| 0.0 | 4.1 | GO:0030133 | transport vesicle(GO:0030133) |
| 0.0 | 5.3 | GO:0031012 | extracellular matrix(GO:0031012) |
| 0.0 | 8.6 | GO:0031965 | nuclear membrane(GO:0031965) |
| 0.0 | 10.3 | GO:0016607 | nuclear speck(GO:0016607) |
| 0.0 | 1.0 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.0 | 0.3 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.0 | 1.3 | GO:0005876 | spindle microtubule(GO:0005876) |
| 0.0 | 0.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 0.0 | 0.0 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
| 0.0 | 0.1 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.0 | 0.2 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
| 0.0 | 0.6 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.7 | 14.2 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
| 3.7 | 14.9 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
| 3.5 | 17.5 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
| 2.9 | 8.6 | GO:0052895 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
| 2.3 | 9.2 | GO:0008112 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
| 2.1 | 4.2 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
| 2.0 | 2.0 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
| 1.5 | 4.6 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 1.4 | 5.6 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 1.4 | 4.2 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
| 1.4 | 4.2 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
| 1.3 | 3.9 | GO:0050429 | calcium-dependent phospholipase C activity(GO:0050429) |
| 1.3 | 3.9 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
| 1.2 | 10.8 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
| 1.2 | 3.6 | GO:0070123 | transforming growth factor beta receptor activity, type III(GO:0070123) |
| 1.2 | 3.6 | GO:0015067 | amidinotransferase activity(GO:0015067) glycine amidinotransferase activity(GO:0015068) |
| 1.2 | 14.0 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
| 1.1 | 3.4 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
| 1.1 | 14.8 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 1.0 | 3.1 | GO:0004020 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
| 0.9 | 4.7 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
| 0.9 | 2.8 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.9 | 5.2 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
| 0.9 | 4.3 | GO:0038025 | reelin receptor activity(GO:0038025) |
| 0.8 | 2.4 | GO:1904928 | coreceptor activity involved in canonical Wnt signaling pathway(GO:1904928) |
| 0.8 | 3.2 | GO:0009041 | uridylate kinase activity(GO:0009041) |
| 0.8 | 2.3 | GO:0050135 | NAD(P)+ nucleosidase activity(GO:0050135) |
| 0.8 | 3.9 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.8 | 9.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
| 0.7 | 2.2 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
| 0.7 | 15.6 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
| 0.7 | 2.2 | GO:0008969 | phosphohistidine phosphatase activity(GO:0008969) |
| 0.7 | 3.5 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 0.7 | 4.1 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
| 0.7 | 2.6 | GO:0099609 | microtubule lateral binding(GO:0099609) |
| 0.6 | 4.4 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
| 0.6 | 12.8 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.6 | 5.0 | GO:0032810 | sterol response element binding(GO:0032810) |
| 0.5 | 12.6 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.5 | 2.2 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
| 0.5 | 8.5 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
| 0.5 | 4.0 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
| 0.5 | 2.9 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.5 | 1.8 | GO:0002060 | purine nucleobase binding(GO:0002060) |
| 0.5 | 5.0 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.4 | 1.8 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 0.4 | 4.0 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
| 0.4 | 9.2 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
| 0.4 | 17.1 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 0.4 | 5.0 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.4 | 1.2 | GO:0016898 | D-lactate dehydrogenase (cytochrome) activity(GO:0004458) oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor(GO:0016898) |
| 0.4 | 1.2 | GO:0005365 | myo-inositol transmembrane transporter activity(GO:0005365) |
| 0.4 | 7.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.4 | 3.2 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
| 0.4 | 11.6 | GO:0005112 | Notch binding(GO:0005112) |
| 0.4 | 3.2 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.4 | 3.6 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.4 | 11.5 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
| 0.4 | 1.2 | GO:0047225 | acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0047225) |
| 0.4 | 6.6 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.4 | 1.2 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
| 0.4 | 1.8 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
| 0.4 | 5.0 | GO:0039706 | co-receptor binding(GO:0039706) |
| 0.4 | 1.4 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
| 0.4 | 15.4 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
| 0.3 | 11.7 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.3 | 3.4 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 0.3 | 2.0 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.3 | 1.0 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
| 0.3 | 2.3 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
| 0.3 | 1.0 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
| 0.3 | 1.3 | GO:0031812 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
| 0.3 | 9.8 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.3 | 3.2 | GO:0016015 | morphogen activity(GO:0016015) |
| 0.3 | 3.2 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.3 | 1.1 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
| 0.3 | 20.3 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.3 | 1.6 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 0.3 | 1.1 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
| 0.3 | 2.3 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 0.3 | 2.6 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.3 | 2.3 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 0.3 | 1.0 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
| 0.3 | 2.0 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.2 | 2.7 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
| 0.2 | 5.8 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
| 0.2 | 2.1 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
| 0.2 | 0.9 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
| 0.2 | 2.1 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 0.2 | 7.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.2 | 1.6 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
| 0.2 | 0.9 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
| 0.2 | 5.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.2 | 1.3 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
| 0.2 | 10.4 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.2 | 0.8 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.2 | 0.8 | GO:0051800 | phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity(GO:0051800) |
| 0.2 | 0.6 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
| 0.2 | 0.8 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
| 0.2 | 3.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.2 | 0.4 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
| 0.2 | 4.0 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.2 | 1.7 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.2 | 1.1 | GO:0032089 | NACHT domain binding(GO:0032089) |
| 0.2 | 1.5 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
| 0.2 | 0.7 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
| 0.2 | 4.1 | GO:0044548 | S100 protein binding(GO:0044548) |
| 0.2 | 3.7 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
| 0.2 | 1.4 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
| 0.2 | 1.4 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
| 0.2 | 1.7 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 0.2 | 5.8 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.2 | 1.3 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
| 0.2 | 0.5 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
| 0.2 | 18.8 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
| 0.2 | 3.5 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.2 | 0.5 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
| 0.2 | 6.3 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
| 0.1 | 0.6 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.1 | 1.5 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.1 | 14.1 | GO:0005179 | hormone activity(GO:0005179) |
| 0.1 | 1.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.1 | 3.9 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
| 0.1 | 1.1 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 0.1 | 0.7 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
| 0.1 | 2.8 | GO:0004017 | adenylate kinase activity(GO:0004017) |
| 0.1 | 4.0 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.1 | 4.1 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.1 | 0.5 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
| 0.1 | 0.6 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 0.1 | 0.9 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.1 | 4.0 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.1 | 5.1 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
| 0.1 | 1.2 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
| 0.1 | 1.5 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.1 | 1.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.1 | 0.9 | GO:0004515 | nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
| 0.1 | 0.3 | GO:0034188 | apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
| 0.1 | 0.9 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.1 | 1.7 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.1 | 0.7 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
| 0.1 | 3.4 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 0.1 | 6.6 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.1 | 0.6 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
| 0.1 | 2.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.1 | 0.4 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 0.1 | 4.8 | GO:0015248 | sterol transporter activity(GO:0015248) |
| 0.1 | 1.0 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 0.1 | 3.3 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
| 0.1 | 1.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.1 | 2.6 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.1 | 0.8 | GO:0070628 | proteasome binding(GO:0070628) |
| 0.1 | 11.6 | GO:0051117 | ATPase binding(GO:0051117) |
| 0.1 | 4.7 | GO:0051183 | vitamin transporter activity(GO:0051183) |
| 0.1 | 2.9 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.1 | 1.5 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.1 | 1.2 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
| 0.1 | 1.1 | GO:0008312 | 7S RNA binding(GO:0008312) |
| 0.1 | 0.7 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 0.1 | 0.5 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.1 | 0.9 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.1 | 7.3 | GO:0005507 | copper ion binding(GO:0005507) |
| 0.1 | 2.9 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.1 | 0.2 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
| 0.1 | 4.3 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.1 | 2.4 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
| 0.1 | 1.0 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
| 0.1 | 5.4 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
| 0.1 | 0.9 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 0.1 | 1.0 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
| 0.1 | 0.6 | GO:0030621 | U4 snRNA binding(GO:0030621) |
| 0.1 | 1.9 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
| 0.1 | 0.3 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 0.1 | 4.4 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
| 0.1 | 0.8 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
| 0.1 | 2.8 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.1 | 8.2 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
| 0.1 | 1.2 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 0.1 | 2.6 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.1 | 0.3 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
| 0.1 | 2.1 | GO:0005158 | insulin receptor binding(GO:0005158) |
| 0.1 | 1.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.1 | 2.2 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
| 0.1 | 0.6 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
| 0.1 | 2.1 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.1 | 0.9 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.1 | 0.4 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
| 0.1 | 0.4 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
| 0.1 | 4.2 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.1 | 1.1 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
| 0.1 | 0.5 | GO:0050656 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
| 0.1 | 5.3 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
| 0.1 | 0.1 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 0.1 | 2.7 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.1 | 2.1 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.1 | 1.5 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.1 | 2.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.1 | 0.3 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
| 0.1 | 2.2 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.1 | 0.6 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.1 | 0.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
| 0.1 | 0.4 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 0.1 | 4.9 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
| 0.0 | 0.4 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 0.0 | 1.0 | GO:0016504 | peptidase activator activity(GO:0016504) |
| 0.0 | 0.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.0 | 0.7 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.0 | 1.3 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.0 | 1.4 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.0 | 0.4 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.0 | 3.5 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
| 0.0 | 0.2 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
| 0.0 | 0.2 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
| 0.0 | 0.9 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 0.0 | 0.5 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
| 0.0 | 0.3 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
| 0.0 | 0.4 | GO:0005113 | patched binding(GO:0005113) |
| 0.0 | 0.6 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
| 0.0 | 0.4 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
| 0.0 | 0.6 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
| 0.0 | 0.4 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 0.0 | 2.1 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.0 | 1.3 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
| 0.0 | 0.2 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.0 | 0.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.0 | 2.2 | GO:0003684 | damaged DNA binding(GO:0003684) |
| 0.0 | 0.6 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
| 0.0 | 6.8 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
| 0.0 | 0.5 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
| 0.0 | 0.9 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.0 | 2.9 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
| 0.0 | 0.6 | GO:0003993 | acid phosphatase activity(GO:0003993) |
| 0.0 | 0.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.0 | 0.5 | GO:0002039 | p53 binding(GO:0002039) |
| 0.0 | 0.2 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 0.0 | 1.1 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.0 | 0.4 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.0 | 0.4 | GO:0034485 | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity(GO:0034485) |
| 0.0 | 0.2 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 0.0 | 0.3 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
| 0.0 | 1.4 | GO:0005254 | chloride channel activity(GO:0005254) |
| 0.0 | 0.2 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.0 | 0.3 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.0 | 0.9 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.0 | 0.3 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
| 0.0 | 0.7 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.0 | 0.0 | GO:0019211 | phosphatase activator activity(GO:0019211) |
| 0.0 | 1.1 | GO:0015103 | inorganic anion transmembrane transporter activity(GO:0015103) |
| 0.0 | 0.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
| 0.0 | 0.5 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.0 | 2.4 | GO:0020037 | heme binding(GO:0020037) |
| 0.0 | 1.8 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.0 | 1.3 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.0 | 0.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 0.0 | 1.8 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
| 0.0 | 0.4 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
| 0.0 | 0.9 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) ubiquitin-like protein ligase binding(GO:0044389) |
| 0.0 | 0.1 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.0 | 0.1 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.0 | 0.1 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 0.0 | 1.2 | GO:0008528 | G-protein coupled peptide receptor activity(GO:0008528) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.6 | 25.9 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.4 | 2.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.3 | 11.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.2 | 16.8 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.2 | 5.5 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.2 | 13.3 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.2 | 1.8 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.2 | 5.7 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.2 | 11.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.2 | 14.3 | PID BMP PATHWAY | BMP receptor signaling |
| 0.1 | 15.5 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.1 | 1.6 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.1 | 0.7 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
| 0.1 | 2.6 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.1 | 1.3 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.1 | 1.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.1 | 4.4 | ST GA12 PATHWAY | G alpha 12 Pathway |
| 0.1 | 4.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.1 | 3.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.1 | 6.0 | PID AP1 PATHWAY | AP-1 transcription factor network |
| 0.1 | 4.0 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.1 | 0.7 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
| 0.1 | 5.7 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.1 | 7.6 | PID SHP2 PATHWAY | SHP2 signaling |
| 0.1 | 3.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.1 | 5.9 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.1 | 4.6 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.1 | 1.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.1 | 1.7 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.1 | 0.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.1 | 1.1 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.1 | 2.8 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.1 | 3.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.1 | 4.3 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.0 | 1.5 | PID EPO PATHWAY | EPO signaling pathway |
| 0.0 | 3.3 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.0 | 0.5 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.0 | 2.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.0 | 1.5 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.0 | 0.5 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.0 | 0.5 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.0 | 0.7 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.0 | 4.1 | PID E2F PATHWAY | E2F transcription factor network |
| 0.0 | 0.4 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.0 | 1.6 | PID INSULIN PATHWAY | Insulin Pathway |
| 0.0 | 0.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
| 0.0 | 0.7 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.0 | 7.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.0 | 0.9 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.0 | 0.4 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.0 | 1.4 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
| 0.0 | 1.7 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
| 0.0 | 1.7 | PID FANCONI PATHWAY | Fanconi anemia pathway |
| 0.0 | 8.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.0 | 0.4 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.0 | 0.3 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
| 0.0 | 0.6 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.0 | 0.5 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
| 0.0 | 6.5 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
| 0.0 | 0.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.0 | 0.4 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.0 | 0.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.0 | 0.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.0 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.6 | 23.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.5 | 15.6 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
| 0.5 | 7.3 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.4 | 20.3 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
| 0.4 | 11.5 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.4 | 7.0 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.4 | 5.1 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
| 0.4 | 3.5 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
| 0.3 | 5.6 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
| 0.3 | 3.0 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
| 0.3 | 14.4 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.3 | 9.9 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
| 0.3 | 8.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.3 | 12.5 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.3 | 6.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.2 | 4.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.2 | 19.4 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
| 0.2 | 3.7 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.2 | 1.6 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
| 0.2 | 3.6 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.2 | 1.5 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.2 | 7.1 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.2 | 1.6 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 0.2 | 3.9 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
| 0.2 | 2.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.2 | 2.8 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
| 0.2 | 0.8 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.2 | 4.3 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.1 | 16.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.1 | 2.1 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.1 | 3.4 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
| 0.1 | 3.8 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
| 0.1 | 3.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.1 | 1.9 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.1 | 10.8 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.1 | 17.4 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.1 | 4.2 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.1 | 6.1 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.1 | 5.6 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.1 | 0.9 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 0.1 | 6.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.1 | 3.7 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.1 | 1.7 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
| 0.1 | 9.0 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
| 0.1 | 5.5 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.1 | 4.4 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.1 | 2.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
| 0.1 | 3.1 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.1 | 8.9 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
| 0.1 | 1.1 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.1 | 1.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.1 | 2.6 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
| 0.1 | 5.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.1 | 1.6 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
| 0.1 | 1.9 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
| 0.1 | 2.2 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.1 | 3.1 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.1 | 1.6 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 0.1 | 0.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.1 | 1.4 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.1 | 3.5 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.1 | 2.2 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 0.1 | 1.8 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.1 | 1.4 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.1 | 2.1 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
| 0.1 | 0.6 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
| 0.1 | 2.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.1 | 1.2 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
| 0.1 | 2.7 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.1 | 2.0 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
| 0.1 | 1.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.1 | 2.3 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.1 | 0.6 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 0.0 | 2.4 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.0 | 0.9 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.0 | 3.1 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
| 0.0 | 1.2 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
| 0.0 | 1.8 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.0 | 1.9 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
| 0.0 | 0.6 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
| 0.0 | 3.5 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.0 | 1.4 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
| 0.0 | 2.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
| 0.0 | 0.7 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.0 | 1.1 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.0 | 1.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.0 | 6.1 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
| 0.0 | 0.6 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.0 | 0.5 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 0.0 | 0.3 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 0.0 | 0.5 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.0 | 0.2 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.0 | 2.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 0.0 | 5.2 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
| 0.0 | 7.1 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
| 0.0 | 1.1 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
| 0.0 | 0.3 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
| 0.0 | 1.0 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
| 0.0 | 1.5 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
| 0.0 | 1.0 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.0 | 0.2 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
| 0.0 | 0.2 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
| 0.0 | 0.6 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.0 | 0.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 0.0 | 0.9 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.0 | 0.7 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.0 | 0.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.0 | 0.0 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
| 0.0 | 0.4 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
| 0.0 | 1.2 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.0 | 0.3 | REACTOME AMYLOIDS | Genes involved in Amyloids |